Debate Over Drug Prices in India, Q&A with Piramal Healthcare CEO

India’s government is facing stiff resistance from foreign and domestic pharmaceutical companies over its plan to limit prices for drugs severely. This video debates the drug prices in India with a Q&A with Piramal Healthcare CEO, Ajay Piramal.

Source: Wall Street Journal. There may be a short advert at the start.

, ,

No comments yet.

Leave a Reply

Read more:
Doctor Evidence and McMaster Partnership

McMaster University Partners with Doctor Evidence to Launch an Integrated Evidence Grading Solution McMaster University and Doctor Evidence have collaborated...

Close